Antihyperlipidemic Drugs Market to Expand on PCSK9 Inhibitors

The Global Antihyperlipidemic Drugs Market is estimated to be valued at USD 15.72 Bn in 2025 and is expected to exhibit a CAGR of 7.5 % over the forecast period...

• prachicmi